Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Public Health & Economic Impact Study
    • Stories of Discovery
    • Chen Lecture Videos
    • NIH Patents and Active Patent Commercialization Licenses
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Patent Applications

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Organization Chart
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NCI

HHV-6 Antibodies

Submitted by ott8admin on Wed, 09/15/2021 - 23:31
  • Read more about HHV-6 Antibodies

Heregulin-β3 (growth factor)

Submitted by ott8admin on Wed, 09/15/2021 - 23:31
  • Read more about Heregulin-β3 (growth factor)

Heat Shock Factor 1

Submitted by ott8admin on Wed, 09/15/2021 - 23:31
  • Read more about Heat Shock Factor 1

Heat Shock Factor

Submitted by ott8admin on Wed, 09/15/2021 - 23:31
  • Read more about Heat Shock Factor

Growth Arrest and DNA Damage-45

Submitted by ott8admin on Wed, 09/15/2021 - 23:31
  • Read more about Growth Arrest and DNA Damage-45

GL-7 antibody against T and B cells

Submitted by ott8admin on Wed, 09/15/2021 - 23:31
  • Read more about GL-7 antibody against T and B cells

GL-1 antibody against T and B cells

Submitted by ott8admin on Wed, 09/15/2021 - 23:31
  • Read more about GL-1 antibody against T and B cells

Fluorognost™ HIV-1 IFA

Submitted by ott8admin on Wed, 09/15/2021 - 23:31
  • Read more about Fluorognost™ HIV-1 IFA

Fluorescent Pteridine-based Nucleoside analog probes

Submitted by ott8admin on Wed, 09/15/2021 - 23:31
  • Read more about Fluorescent Pteridine-based Nucleoside analog probes

Fibronectin Fragment

Submitted by ott8admin on Wed, 09/15/2021 - 23:31
  • Read more about Fibronectin Fragment

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 1687
  • Page 1688
  • Page 1689
  • Page 1690
  • Page 1691
  • Page 1692
  • Page 1693
  • Page 1694
  • Page 1695
  • …
  • Next page ››
  • Last page Last »
Subscribe to NCI
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health